How often can you take the morning-after pill?

Unprotected intercourse or failure of a regular contraceptive method can be an acute source of worry. Emergency contraception (EC), commonly known as the “morning-after pill,” offers a time-sensitive option to reduce the risk of unintended pregnancy after such events. This article explains how emergency contraceptives work, the available options, their effectiveness and timing, safety considerations for repeated use, interactions with ongoing contraception, special situations (including breastfeeding), and when to seek medical care. Clinical guidance from leading organizations (ACOG, NIH, Mayo Clinic, Cleveland Clinic) is cited throughout.

What is “the morning-after pill”?

“Morning-after pill” is a lay term generally applied to oral emergency contraceptives. In clinical practice, emergency contraception refers to interventions used after unprotected intercourse or contraceptive failure to prevent pregnancy. Emergency contraception options available in many countries include:

  • Oral levonorgestrel (LNG) pills (commonly available over the counter)
  • Oral ulipristal acetate (UPA) pills (prescription)
  • Copper-bearing intrauterine device (IUD) inserted as emergency contraception

Each option has different mechanisms, timing windows, and relative effectiveness; choosing the appropriate method depends on timing, medical history, and access to services (ACOG; Mayo Clinic; NIH; Cleveland Clinic).

How do emergency contraceptives work?

Mechanisms differ by method:

  • Levonorgestrel (LNG) pill: LNG is a progestin that primarily prevents or delays ovulation when taken before the luteinizing hormone surge that triggers ovulation. It may also alter cervical mucus to impede sperm transport. LNG is not effective once fertilization and implantation have occurred; it does not interrupt an established pregnancy (ACOG; Mayo Clinic).
  • Ulipristal acetate (UPA) pill: UPA is a selective progesterone receptor modulator. It is more effective than LNG at delaying ovulation even when the luteinizing hormone has begun to rise. Like LNG, it will not terminate an established pregnancy (ACOG; NIH).
  • Copper IUD: The copper IUD prevents fertilization primarily by creating a local inflammatory environment that is toxic to sperm and inhibits fertilization. Insertion as emergency contraception offers the highest effectiveness and provides ongoing long-term contraception (ACOG; Mayo Clinic).

(References: ACOG Committee Opinions and patient education resources; Mayo Clinic; NIH MedlinePlus.)

Timing and effectiveness of different options

Timing of administration is critical in determining the effectiveness of emergency contraception.

Levonorgestrel (LNG) pills

  • Most effective if taken as soon as possible after unprotected intercourse; manufacturer guidance and major clinical sources recommend use within 72 hours (3 days).
  • Effectiveness decreases with time after intercourse; LNG is less effective than UPA and markedly less effective than a copper IUD (Mayo Clinic; ACOG).

Ulipristal acetate (UPA) pills

  • UPA can be taken up to 120 hours (5 days) after unprotected intercourse and maintains relatively higher efficacy than LNG across this interval.
  • UPA requires a prescription in many jurisdictions and has different interactions with hormonal contraceptives (ACOG; Mayo Clinic).

Copper IUD

  • When inserted by a trained clinician, a copper IUD is the most effective emergency contraceptive and can be used within 5 days of unprotected intercourse (some guidelines allow insertion up to 5 days after ovulation or within the timeframe consistent with emergency use).
  • The copper IUD provides immediate and ongoing contraception and should be discussed with a clinician for suitability (ACOG; Mayo Clinic).

(For specific effectiveness percentages: studies and meta-analyses vary by population and timing; counseling should emphasize relative rather than absolute numbers, and that copper IUD provides the highest degree of pregnancy prevention.)

How often can you take the morning-after pill?

Medical safety of repeated use

  • There is no evidence that occasional repeated use of levonorgestrel emergency contraception causes long-term health harms or reduces future fertility. Major professional organizations acknowledge that LNG EC may be used more than once in a menstrual cycle if clinically indicated (ACOG).
  • However, repeated reliance on emergency contraception is not recommended as a routine method of birth control because it is less effective at preventing pregnancy than regular contraceptive methods, can cause menstrual irregularities, and does not protect against sexually transmitted infections (STIs) (ACOG; NIH; Mayo Clinic).

Practical considerations for frequency

  • Levonorgestrel (OTC): It can be taken more than once in a cycle if necessary, but repeated use may lead to irregular bleeding or cycle disturbance in the short term. There is no defined “maximum number of times” from a strictly safety perspective; the emphasis is clinical appropriateness and counseling toward reliable regular methods (ACOG).
  • Ulipristal acetate (UPA): Repeated use in the same cycle has not been extensively studied; caution is warranted because UPA can interact with progestin-based contraception if taken too closely together. If emergency UPA is used, discuss timing of resuming or starting hormonal contraception with a clinician (ACOG; Mayo Clinic).
  • Copper IUD: Because it provides long-term contraception, once placed it eliminates the need for repeated emergency pills.

Why frequent use is discouraged

  • Reduced effectiveness: Repeated EC provides episodic protection and is less effective than routine contraception such as combined hormonal methods, progestin-only methods, implants, or intrauterine devices (IUDs).
  • Menstrual disruption: Multiple doses within a cycle may increase the risk of irregular bleeding, heavier or lighter menses, or altered timing of the next period.
  • Missed opportunity: Frequent use signals a need to review contraceptive planning and consider a more reliable method (long-acting reversible contraception, depot injections, oral contraceptives, barrier options) tailored to the individual’s needs and preferences (ACOG; NIH).

Side effects and what to expect

Common short-term side effects for oral EC include:

  • Nausea and sometimes vomiting (if vomiting occurs within two hours of dosing, the dose may need to be repeated)
  • Fatigue, dizziness, headache
  • Breast tenderness
  • Temporary changes to the next menstrual period (earlier or later, lighter or heavier bleeding)
  • For copper IUD insertion: cramping and discomfort during insertion, and heavier menses or cramping for some individuals afterward (Mayo Clinic; Cleveland Clinic).

If the next expected period is delayed by more than one week after the expected date, or if bleeding is unusually heavy or accompanied by severe pain, clinical evaluation is advised to exclude pregnancy or other complications (ACOG; NIH).

Interactions with regular hormonal contraception

  • If ulipristal acetate (UPA) is used, starting or resuming progestin-containing hormonal contraception should be delayed for at least 5 days because progestins may reduce the effectiveness of UPA. A reliable nonhormonal barrier method (e.g., condoms) should be used during this interval. After 5 days, hormonal contraception may be initiated, and if this provides ongoing protection, continue as indicated (ACOG; Mayo Clinic).
  • Levonorgestrel EC does not require delaying the initiation or resumption of hormonal contraception. If you take an LNG EC pill and plan to start or continue combined or progestin-only contraception, you may do so according to usual guidance; some clinicians recommend using a backup barrier method for 7 days for certain methods (ACOG; Mayo Clinic).
  • Be aware of drug interactions: certain medications (strong enzyme inducers such as some anticonvulsants, rifampin, some herbal supplements like St. John’s wort) may reduce the effectiveness of oral EC. Discuss medication history with your clinician or pharmacist (NIH; ACOG).

Emergency contraception and breastfeeding

  • Levonorgestrel: Considered acceptable for breastfeeding individuals. Small amounts of levonorgestrel are excreted into breast milk, but it is generally regarded as compatible with breastfeeding. If concerned, review the latest guidance with a clinician (Mayo Clinic; NIH).
  • Ulipristal acetate: Limited data exist on secretion into breast milk; many clinicians recommend avoiding breastfeeding for a short interval after UPA, or discuss alternatives. Consult a provider for individualized advice (Mayo Clinic; ACOG).
  • Copper IUD: Compatible with breastfeeding and may be an excellent option for those seeking long-term contraception postpartum (ACOG; Mayo Clinic).

Because recommendations may vary by jurisdiction and updated evidence, breastfeeding individuals should consult clinical guidance sources or their clinician for the most current advice.

Emergency contraception is not an abortion method

  • Emergency contraception prevents pregnancy by delaying ovulation or preventing fertilization; it does not terminate an established pregnancy and will not be effective if implantation has already occurred. If pregnancy is known or suspected, emergency contraception should not be used as a means to end pregnancy (ACOG; NIH).

Impact on future fertility

  • Use of emergency contraception, including repeated use of LNG or insertion and subsequent removal of a copper IUD, has not been shown to impair long-term fertility. Individuals who desire future pregnancy should be counseled that neither LNG nor UPA permanently affects fertility; the copper IUD is reversible upon removal (ACOG; NIH).

When to seek medical attention

Seek immediate clinical evaluation if:

  • You suspect you are pregnant after using emergency contraception (e.g., missed period, persistent pregnancy symptoms). Confirmatory testing is appropriate.
  • You experience severe abdominal pain after a positive pregnancy test (consider evaluation for ectopic pregnancy).
  • You have prolonged heavy vaginal bleeding or severe pelvic pain after copper IUD insertion.
  • You experience severe or persistent side effects after oral EC (prolonged vomiting, severe dizziness) (ACOG; NIH; Mayo Clinic).

If you repeatedly find yourself using emergency contraception, arrange an appointment to review contraceptive options that offer greater and more consistent protection.

Choosing a routine contraceptive method instead of repeated EC

Emergency contraception is intended for occasional, unplanned events. For ongoing pregnancy prevention, consider discussing these options with your clinician:

  • Long-acting reversible contraceptives (LARCs): intrauterine devices (copper or hormonal) and subdermal implants — highly effective, minimal need for user action, suitable for many people (ACOG).
  • Combined hormonal contraception (pill, patch, vaginal ring) — effective when used correctly, with attention to contraindications.
  • Progestin-only methods (pills, injectable depot medroxyprogesterone, implant) — effective alternatives for those who cannot use estrogen-containing methods.
  • Barrier methods (male or female condoms, diaphragms) — may be used in combination with other methods and provide STI protection when used correctly (ACOG; NIH).

Choosing a method involves assessment of medical history, preferences, contraindications, and desire for future fertility.

Access and cost considerations

  • In many countries, levonorgestrel emergency contraceptives are available over the counter without age restriction. Ulipristal acetate often requires a prescription. Copper IUD insertion requires a clinical visit.
  • Insurance coverage varies by jurisdiction and policy; many public and private programs provide coverage or subsidized access. Sexual assault survivors may have access to emergency contraception and STI prophylaxis through specialized services; local resources and clinician offices can advise (Mayo Clinic; Cleveland Clinic).

Myths and frequently asked questions

  • “Taking emergency contraception will make me sterile.” False. There is no evidence that EC causes permanent infertility.
  • “I can use the morning-after pill as my regular birth control.” Not recommended. EC is less effective than routine contraception and does not protect against STIs. If frequent EC use occurs, consult a clinician for a reliable method.
  • “If I’m already pregnant, EC will cause miscarriage.” False. EC will not abort an established pregnancy.
  • “EC causes severe hormonal damage.” Occasional use may cause short-term menstrual changes, but serious long-term hormonal damage has not been demonstrated (ACOG; NIH; Mayo Clinic).

Counseling points clinicians should provide (and patients should expect)

  • Explain the relative effectiveness and time-sensitivity of LNG, UPA, and copper IUD.
  • Review potential side effects and what to do in the event of vomiting soon after dosing.
  • Discuss interactions with current medications and the timing for starting or resuming regular hormonal contraception, particularly after UPA.
  • Emphasize that EC is for emergency use, encourage discussion of reliable routine contraception, and address STI prevention and screening needs (ACOG).

Summary and practical recommendations

  • Emergency contraception is an important, time-sensitive option to reduce pregnancy risk after unprotected intercourse or contraceptive failure. Options include oral levonorgestrel (OTC), oral ulipristal acetate (prescription), and the copper IUD (clinician-inserted).
  • Levonorgestrel may be used more than once when clinically necessary and is not associated with long-term harm; however, repeated use is not recommended as routine contraception because of reduced effectiveness relative to regular methods and possible short-term menstrual disturbances (ACOG).
  • Ulipristal offers better efficacy up to 120 hours but has specific timing considerations with hormonal contraception.
  • The copper IUD is the most effective emergency option and provides ongoing contraception.
  • If you find yourself using emergency contraception frequently, consult a clinician to select a more reliable contraceptive method and discuss individualized care.

For up-to-date and personalized advice, contact your healthcare provider or consult professional resources such as ACOG, NIH/MedlinePlus, Mayo Clinic, and Cleveland Clinic.

References and further reading

  • American College of Obstetricians and Gynecologists (ACOG). Committee Opinions and patient education on Emergency Contraception. https://www.acog.org
  • National Institutes of Health (NIH) / MedlinePlus: Emergency contraception. https://medlineplus.gov/emergencycontraception.html
  • Mayo Clinic. Emergency contraception: Options and effectiveness. https://www.mayoclinic.org/tests-procedures/emergency-contraception/about/pac-20394713
  • Cleveland Clinic. Emergency contraception: Types, effectiveness, side effects. https://my.clevelandclinic.org/health/treatments/9306-emergency-contraception

(These resources provide clinical guidance for patients and clinicians and are a starting point for individualized counseling.)